Skip to main content
Fig. 1 | BMC Surgery

Fig. 1

From: Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol

Fig. 1

Clinical flowchart Performance trial. BSC: Best supportive care; WP: Work Package; MDT: Multidisciplinary Team; BR: Borderline resectable pancreatic ductal adenocarcinoma; LA: Locally advanced pancreatic ductal adenocarcinoma; PDAC: Pancreatic ductal adenocarcinoma; CT: Computed Tomography; MRI: Magnetic resonance imaging

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us